Seven & I Shares Rise as Artisan Partners Urges Consideration of Buyout Offer
By Megumi Fujikawa
TOKYO--Shares of Seven & i Holdings rose nearly 3% on Monday after its U.S. shareholder, Artisan Partners, urged the company to seriously consider an acquisition proposal made by Alimentation Couche-Tard.
In a letter to Seven & i dated Friday, Artisan Partners said "it is imperative that the board of directors negotiate with [Alimentation Couche-Tard] immediately to achieve the best possible outcome for shareholders."
Shares of the Japanese owner of 7-Eleven convenience stores hit an intraday high of 2185.0 yen, the equivalent of $14.95, Monday afternoon before closing 2.8% higher at 2156.5 yen.
Artisan Partners asked Seven & i to brief its shareholders on the status of the takeover negotiations by Sept. 19. It has a 1.15% stake in Seven & i, according to Factset.
Seven & i has said it set up a special committee to examine the offer but hasn't decided whether it would open talks with the Canadian owner of Circle K.
Some analysts say Artisan Partners' letter lacks concrete advice.
"It is basically a letter airing its frustration," Travis Lundy of Quiddity Advisors, who publishes on Smartkarma, said in a note.
It offers no ideas about value or business analysis, and doesn't have any suggestions about how to get more value out of the situation, Lundy said.
Lundy said he would remain long on Seven & i shares and buy on dips.
Write to Megumi Fujikawa at megumi.fujikawa@wsj.com
(END) Dow Jones Newswires
September 02, 2024 02:34 ET (06:34 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks